Skip to main content
. 2016 Mar 7;11(3):e0150721. doi: 10.1371/journal.pone.0150721

Fig 5. Distribution of MATS strains predicted to be covered by cc and specific vaccine antigen combinations.

Fig 5

Strains were defined as covered if they possessed PorA P1.4 or had relative potency greater than the positive bactericidal threshold for fHbp, NHBA or NadA. *NA: Clonal complex non assigned.